Related Experiment Video
Updated: Jul 23, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Assessing the Link Between Statins and Insulin Intolerance: A Systematic Review
Karan Nareshbhai Dabhi1, Namra V Gohil1,2, Nida Tanveer1
1Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Statin use may negatively impact blood sugar control, decreasing insulin sensitivity and increasing insulin resistance. This systematic review highlights potential adverse effects for patients on statin therapy, particularly those at risk for diabetes.
Area of Science:
- Endocrinology
- Pharmacology
- Metabolic Syndrome
Background:
- Mixed evidence exists on statin use and insulin intolerance.
- Understanding this relationship is crucial for patient management and diabetes risk assessment.
Purpose of the Study:
- To systematically review and synthesize evidence on the association between statin therapy and insulin intolerance.
- To clarify the impact of statins on insulin sensitivity and resistance.
Main Methods:
- Systematic literature search of MEDLINE, PubMed, PubMed Central (PMC), and Google Scholar.
- Inclusion of 11 full-text English articles from 667 initially identified studies.
- Analysis of data from a total of 46,728,889 participants.
Main Results:
- Statin use was associated with decreased insulin sensitivity.
- Statin use was linked to increased insulin resistance.
- Evidence suggests a potential adverse effect on glucose metabolism.
Conclusions:
- Statin therapy may negatively affect insulin sensitivity and increase insulin resistance.
- Findings have clinical implications for statin users, especially those at risk of diabetes.
- Further research may be warranted to explore mechanisms and clinical management strategies.
More Related Videos
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides
Insulin: The Receptor and Signaling Pathways
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...